FDA Sends Mixed Message On Labeling Authority: Is Website Enough?

FDA's planned "Drug Watch" website could render proposals to give the agency authority to mandate drug labeling changes and postmarketing safety studies unnecessary, FDA Acting Deputy Commissioner for Operations Janet Woodcock told the Senate Health Committee

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet